Clinical Study
Muscle-Derived Cells for Treatment of Iatrogenic Sphincter Damage and Urinary Incontinence in Men
Table 1
Patient characteristics at baseline.
| Age | | Mean age | 70 (56–81) | Previous surgery | | Radical prostatectomy | 192 (87%) | TUR-P | 9 (4%) | Radical cystectomy with neobladder | 21 (9%) | Previous therapy approaches | | Pelvic floor muscle training (PFMT) | 178 (80%) | Transcutaneous electrical nerve stimulation | 32 (14%) | Behavioural therapies | 66 (30%) | Pharmacologic treatment (duloxetine) | 182 (82%) | Duration of previous incontinence | | Overall months | 49 (12–192) | 12–24 months | 69 (31%) | 24–50 months | 117 (53%) | 50–100 months | 32 (14%) | 100–192 months | 4 (2%) |
|
|